Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2984)
All Articles published online
|
Nov 7, 2006 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tong MJ, Blatt LM, Kao JH, Cheng JT, Corey WG. Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma. World J Gastroenterol 2006; 12(41): 6620-6626 [PMID: 17075974 DOI: 10.3748/wjg.v12.i41.6620] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i41/6620.htm |
| Number | Citing Articles |
| 1 |
Nahed A. Makhlouf, Khairy H. Morsy, Essam-Eldin R. Othman, Eman Nasr Eldin. Ante-natal screening of pregnant women for hepatitis B virus infection in Upper Egypt. Egyptian Liver Journal 2014; 4(2): 57 doi: 10.1097/01.ELX.0000445723.55972.3a
|
| 2 |
Myron John Tong, Leeyen Hsu, Carlos Hsien, Jia-Horng Kao, Francisco Antonio Durazo, Sammy Saab, Lawrence Mitchell Blatt. A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection. Hepatology International 2010; 4(2): 516 doi: 10.1007/s12072-010-9179-1
|
| 3 |
Lindsay A. Uribe, Connor G. O’Brien, Robert J. Wong, Robert R. Gish, Naoky Tsai, Mindie H. Nguyen. Current Treatment Guidelines for Chronic Hepatitis B and Their Applications. Journal of Clinical Gastroenterology 2014; 48(9): 773 doi: 10.1097/MCG.0000000000000130
|
| 4 |
|
| 5 |
Myron J. Tong, Lawrence M. Blatt, Jia‐Horng Kao, Jason Tzuying Cheng, William G. Corey. Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen‐positive hepatocellular carcinoma: a comparison with chronic carriers. Liver International 2007; 27(10): 1356 doi: 10.1111/j.1478-3231.2007.01585.x
|
| 6 |
Wen‐Chun Liu, I‐Chin Wu, Yen‐Chien Lee, Chih‐Peng Lin, Ji‐Hong Cheng, Yih‐Jyh Lin, Chia‐Jui Yen, Pin‐Nan Cheng, Pei‐Fu Li, Yi‐Ting Cheng, Pei‐Wen Cheng, Koun‐Tem Sun, Shu‐Ling Yan, Jia‐Jhen Lin, Jui‐Chu Yang, Kung‐Chao Chang, Cheng‐Hsun Ho, Vincent S Tseng, Bill Chia‐Han Chang, Jaw‐Ching Wu, Ting‐Tsung Chang. Hepatocellular carcinoma‐associated single‐nucleotide variants and deletions identified by the use of genome‐wide high‐throughput analysis of hepatitis B virus. The Journal of Pathology 2017; 243(2): 176 doi: 10.1002/path.4938
|
| 7 |
Abdulrahim Hakami, Abdelwahid Ali, Ahmed Hakami. Effects of Hepatitis B Virus Mutations on its Replication and Liver Disease Severity. The Open Virology Journal 2013; 7(1): 12 doi: 10.2174/1874357901307010012
|
| 8 |
Hui-Hui Tan, Paul Martin. Current treatment of chronic HBV infection: A North American perspective. Current Hepatitis Reports 2009; 8(4): 148 doi: 10.1007/s11901-009-0021-y
|
| 9 |
Osamu Yokosuka, Masayuki Kurosaki, Fumio Imazeki, Yasuji Arase, Yasuhito Tanaka, Kazuaki Chayama, Eiji Tanaka, Hiromitsu Kumada, Namiki Izumi, Masashi Mizokami, Masatoshi Kudo. Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009. Hepatology Research 2011; 41(1): 1 doi: 10.1111/j.1872-034X.2010.00739.x
|
| 10 |
Atsunori Kusakabe, Yasuhito Tanaka, Manami Inoue, Fuat Kurbanov, Kanako Tatematsu, Shunsuke Nojiri, Takashi Joh, Shoichiro Tsugane, Masashi Mizokami. A population-based cohort study for the risk factors of HCC among hepatitis B virus mono-infected subjects in Japan. Journal of Gastroenterology 2011; 46(1): 117 doi: 10.1007/s00535-010-0307-4
|
| 11 |
Giovanna Fattovich, Flavia Bortolotti, Francesco Donato. Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors. Journal of Hepatology 2008; 48(2): 335 doi: 10.1016/j.jhep.2007.11.011
|
| 12 |
Jeyanthi Suppiah, Rozainanee Mohd Zain, Norazlah Bahari, Salbiah Haji Nawi, Zainah Saat. G1896A Precore Mutation and Association With HBeAg Status, Genotype and Clinical Status in Patients With Chronic Hepatitis B. Hepatitis Monthly 2015; 15(10) doi: 10.5812/hepatmon.31490
|
| 13 |
Guang-Wen Cao. Clinical relevance and public health significance of hepatitis B virus genomic variations. World Journal of Gastroenterology 2009; 15(46): 5761-5769 doi: 10.3748/wjg.15.5761
|
| 14 |
Chih‐Lin Lin, Tai‐Chung Tseng, Jia‐Horng Kao. What can we learn from hepatitis B virus clinical cohorts?. Liver International 2015; 35(s1): 91 doi: 10.1111/liv.12716
|
| 15 |
Jia-Horng Kao, Pei-Jer Chen, Ding-Shinn Chen. . Advances in Cancer Research 2010; 108: 21 doi: 10.1016/B978-0-12-380888-2.00002-9
|
| 16 |
Hung-Chih Yang, Tung-Hung Su. Hepatitis B Virus and Liver Disease. 2021; : 205 doi: 10.1007/978-981-16-3615-8_9
|
| 17 |
Hepatitis B virus infection in children of HBV-related chronic liver disease patients: a study of intra-familial HBV transmission. Hepatology International 2017; 11(1): 96 doi: 10.1007/s12072-016-9764-z
|
| 18 |
Amar S. Shah, Valerie F. Civelli, Varun Bali, Royce H. Johnson, Arash Heidari. A Case of S-Variant Hepatitis B Virus: An Immune System Escape Artist. Journal of Investigative Medicine High Impact Case Reports 2021; 9 doi: 10.1177/23247096211045450
|
| 19 |
Chaojun Zhang, Sanchun An, Ruibo Lv, Kezhi Li, Haizhou Liu, Jilin Li, Yanping Tang, Zhengmin Cai, Tianren Huang, Long Long, Wei Deng. The dynamic variation position and predominant quasispecies of hepatitis B virus: Novel predictors of early hepatocarcinoma. Virus Research 2024; 341: 199317 doi: 10.1016/j.virusres.2024.199317
|
| 20 |
Jia-Horng Kao. Role of viral factors in the natural course and therapy of chronic hepatitis B. Hepatology International 2007; 1(4): 415 doi: 10.1007/s12072-007-9033-2
|
| 21 |
M. J. Tong, C. Q. Pan, S.‐H. B. Han, D. S.‐K. Lu, S. Raman, K.‐Q. Hu, J. K. Lim, H. W. Hann, A. D. Min. An expert consensus for the management of chronic hepatitis B in Asian Americans. Alimentary Pharmacology & Therapeutics 2018; 47(8): 1181 doi: 10.1111/apt.14577
|
| 22 |
Myron J. Tong, Hai-En Sun, Carlos Hsien, David S. K. Lu. Surveillance for Hepatocellular Carcinoma Improves Survival in Asian-American Patients with Hepatitis B: Results from a Community-Based Clinic. Digestive Diseases and Sciences 2010; 55(3): 826 doi: 10.1007/s10620-009-1059-y
|
| 23 |
María Mora González López Ledesma, Omar Galdame, Belén Bouzas, Luciana Tadey, Beatriz Livellara, Silvina Giuliano, Marcela Viaut, Silvia Paz, Hugo Fainboim, Adrian Gadano, Rodolfo Campos, Diego Flichman. Characterization of the basal core promoter and precore regions in anti-HBe-positive inactive carriers of hepatitis B virus. International Journal of Infectious Diseases 2011; 15(5): e314 doi: 10.1016/j.ijid.2010.12.009
|
| 24 |
Ileana Constantinescu, Andrei-Antoniu Dinu, Voicu Boscaiu, Marius Niculescu. Hepatitis B Virus Core Promoter Mutations in Patients With Chronic Hepatitis B and Hepatocellular Carcinoma in Bucharest, Romania. Hepatitis Monthly 2014; 14(10) doi: 10.5812/hepatmon.22072
|
| 25 |
Chih‐Lin Lin, Jia‐Horng Kao. Risk stratification for hepatitis B virus related hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2013; 28(1): 10 doi: 10.1111/jgh.12010
|
| 26 |
Thi Ton Taht Bui, Tan Thanh Tran, My Ngoc Nghiem, Pierre Rahman, Thi Thanh Thanh Tran, Man Nguyen Huy Dinh, Manh Hung Le, Van Vinh Chau Nguyen, Guy Thwaites, Motiur Rahman. Molecular characterization of hepatitis B virus in Vietnam. BMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-017-2697-x
|
| 27 |
Myron John Tong, Carlos Hsien, Leeyen Hsu, Hai‐En Sun, Lawrence Mitchell Blatt. Treatment recommendations for chronic hepatitis B. Hepatology 2008; 48(4): 1070 doi: 10.1002/hep.22476
|
| 28 |
Ying-Hsiu Su, Selena Y Lin, Wei Song, Surbhi Jain. DNA markers in molecular diagnostics for hepatocellular carcinoma. Expert Review of Molecular Diagnostics 2014; 14(7): 803 doi: 10.1586/14737159.2014.946908
|
| 29 |
Myron John Tong, Leeyen Hsu, Patrick W Chang, Lawrence Mitchell Blatt. Evaluation of current treatment recommendations for chronic hepatitis B: A 2011 update. Journal of Gastroenterology and Hepatology 2011; 26(5): 829 doi: 10.1111/j.1440-1746.2011.06623.x
|
| 30 |
Hung-Chih Yang, Yi-Fen Shih, Chun-Jen Liu. Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B. The Journal of Infectious Diseases 2017; 216(suppl_8): S757 doi: 10.1093/infdis/jix461
|
| 31 |
Man-Fung Yuen, Yasuhito Tanaka, Daniel Yee-Tak Fong, James Fung, Danny Ka-Ho Wong, John Chi-Hang Yuen, David Yiu-Kuen But, Annie On-On Chan, Benjamin Chun-Yu Wong, Masashi Mizokami, Ching-Lung Lai. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. Journal of Hepatology 2009; 50(1): 80 doi: 10.1016/j.jhep.2008.07.023
|
| 32 |
Saad Zaky, Ahlam Mohamed Farghaly, Hebat-Allah Rashed, Hywida Hassan, Ehab Faouzy, Nahed Makhlouf, Mahmoud Rezk Abdelwahed Hussein. Clinicopathologic features and genotyping of patients with chronic HBV infection in the Upper Egypt. Cellular Immunology 2010; 265(2): 97 doi: 10.1016/j.cellimm.2010.07.008
|
| 33 |
Yan Geng, Xiangling Wang, Xiaolan Lu, Xiaokang Wu, Nan Xu, Lei Han, Jiru Xu. Mutation Changes in the preC/Core Promoter in HBeAg-Positive Patients With Chronic Hepatitis B During Interferon Therapy. Medicine 2016; 95(5): e2657 doi: 10.1097/MD.0000000000002657
|
| 34 |
Chih-Lin Lin, Jia-Horng Kao. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B. Journal of Biomedical Science 2008; 15(2): 137 doi: 10.1007/s11373-007-9225-8
|
| 35 |
Myron John Tong, Michael Ong Nguyen, Lori Terese Tong, Lawrence Mitchell Blatt. Development of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen. Clinical Gastroenterology and Hepatology 2009; 7(8): 889 doi: 10.1016/j.cgh.2009.04.012
|
| 36 |
Brent C. Taylor, Jian-Min Yuan, Tatyana A. Shamliyan, Aasma Shaukat, Robert L. Kane, Timothy J. Wilt. Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence # †. Hepatology 2009; 49(Suppl. 5): S85 doi: 10.1002/hep.22929
|
| 37 |
Chang Hee Yang, Byung-Cheol Song, Moonjae Cho. A natural mutation of the hepatitis B virus X gene affects cell cycle progression and apoptosis in Huh7 cells. Journal of the Korean Society for Applied Biological Chemistry 2012; 55(2): 229 doi: 10.1007/s13765-012-2012-x
|
| 38 |
Hung-Chih Yang, Jia-Horng Kao. Revisiting the Natural History of Chronic HBV Infection. Current Hepatology Reports 2016; 15(3): 141 doi: 10.1007/s11901-016-0304-z
|
| 39 |
Yandi Xie, Hui Ma, Bo Feng, Guangjun Song. Combining the HBcrAg decline and HBV mutations predicts spontaneous HBeAg seroconversion in chronic hepatitis B patients during the immune clearance phase. Journal of Medical Virology 2022; 94(6): 2694 doi: 10.1002/jmv.27545
|
| 40 |
Myron John Tong, Carlos Hsien, Joanna Jungeun Song, Jia Horng Kao, Hai-En Sun, Leeyen Hsu, Steven-Huy Han, Francisco Antonio Durazo, Sammy Saab, Lawrence Mitchell Blatt. Factors Associated with Progression to Hepatocellular Carcinoma and to Death from Liver Complications in Patients with HBsAg-Positive Cirrhosis. Digestive Diseases and Sciences 2009; 54(6): 1337 doi: 10.1007/s10620-009-0747-y
|
| 41 |
A.K. Agarwal, Sourav Sen, Debabrata Banerjee, Rakesh Srivastava, A.K. Praharaj. Distribution of hepatitis B virus genotype and cancer predicting precore and basal core promoter mutations. Medical Journal Armed Forces India 2015; 71(3): 225 doi: 10.1016/j.mjafi.2015.04.003
|
| 42 |
Kazuo Tarao, Akito Nozaki, Takaaki Ikeda, Akira Sato, Hirokazu Komatsu, Tatsuji Komatsu, Masataka Taguri, Katsuaki Tanaka. Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment. Cancer Medicine 2019; 8(3): 1054 doi: 10.1002/cam4.1998
|
| 43 |
Ilan S. Weisberg, Robert S. Brown, Samuel H. Sigal. Hepatitis B and End-Stage Liver Disease. Clinics in Liver Disease 2007; 11(4): 893 doi: 10.1016/j.cld.2007.08.009
|
| 44 |
Sohair K. Sayed, Mohammad A. kobeisy. The relationship between core promoter mutation of hepatitis B virus, viral load and hepatitis B e antigen status in chronic hepatitis B patients. Cellular Immunology 2012; 276(1-2): 35 doi: 10.1016/j.cellimm.2012.03.003
|
| 45 |
Elena Raffetti, Giovanna Fattovich, Francesco Donato. Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta‐analysis. Liver International 2016; 36(9): 1239 doi: 10.1111/liv.13142
|
| 46 |
Myron J. Tong, Calvin Q. Pan, Hie-Won Hann, Kris V. Kowdley, Steven-Huy B. Han, Albert D. Min, Truong-Sinh Leduc. The Management of Chronic Hepatitis B in Asian Americans. Digestive Diseases and Sciences 2011; 56(11): 3143 doi: 10.1007/s10620-011-1841-5
|
| 47 |
Myron J. Tong, Judy Trieu. Hepatitis B inactive carriers: Clinical course and outcomes. Journal of Digestive Diseases 2013; 14(6): 311 doi: 10.1111/1751-2980.12051
|
| 48 |
Shijian Liu, Hongwei Zhang, Chunying Gu, Jianhua Yin, Yongchao He, Jiaxin Xie, Guangwen Cao. Associations Between Hepatitis B Virus Mutations and the Risk of Hepatocellular Carcinoma: A Meta-Analysis. JNCI: Journal of the National Cancer Institute 2009; 101(15): 1066 doi: 10.1093/jnci/djp180
|
| 49 |
Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction?. International Journal of Infectious Diseases 2015; 41: 83 doi: 10.1016/j.ijid.2015.11.002
|
| 50 |
Khairy H. Morsy, Mohamed A. A. Ghaliony, Tarek T. H. ElMel egy. Clinical, laboratory, and virological characteristics of patients with positive hepatitis B surface antigen in Upper Egypt. The Egyptian Journal of Internal Medicine 2015; 27(1): 32 doi: 10.4103/1110-7782.155853
|
| 51 |
Tao-Tao Liu, Ying Fang, Hui Xiong, Tao-Yang Chen, Zheng-Pin Ni, Jian-Feng Luo, Nai-Qing Zhao, Xi-Zhong Shen. A case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong, China. World Journal of Gastroenterology 2008; 14(19): 3059-3063 doi: 10.3748/wjg.14.3059
|
| 52 |
Myron John Tong, Thatcher Thi Huynh, Surachate Siripongsakun. Familial clustering of hepatocellular carcinoma in HBsAg-positive patients in the United States. Hepatology International 2013; 7(4): 1019 doi: 10.1007/s12072-013-9447-y
|
| 53 |
Myron John Tong, Thatcher Thi Huynh, Surachate Siripongsakun, Patrick Weijen Chang, Lori Terese Tong, Yen Phi Ha, Edward Alphonso Mena, Matthew Frank Weissman. Predicting clinical outcomes in patients with HBsAg-positive chronic hepatitis. Hepatology International 2015; 9(4): 567 doi: 10.1007/s12072-015-9651-z
|
| 54 |
Yurong Gu, Yifan Lian, Lin Gu, Lubiao Chen, Xiaoyan Li, Liang Zhou, Yanlin Huang, Jialiang Wang, Yuehua Huang. Correlations between cytokines produced by T cells and clinical-virological characteristics in untreated chronic hepatitis B patients. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-3853-2
|
| 55 |
Hatef Massoumi, Paul Martin, Hui-Hui Tan. Management of chronic hepatitis B. European Journal of Gastroenterology & Hepatology 2011; 23(8): 642 doi: 10.1097/MEG.0b013e3283474add
|
| 56 |
Myoung Ha Lee, Do Young Kim, Ja Kyung Kim, Hye Young Chang, Se Hun Kang, Han Jak Ryu, Hye-Lim Ju, Seung Up Kim, Jung Min Lee, Jun Yong Park, Kwang-Hyub Han, Chae Yoon Chon, Sang Hoon Ahn. Combination of preS Deletions and A1762T/G1764A Mutations in HBV Subgenotype C2 Increases the Risk of Developing HCC. Intervirology 2012; 55(4): 112 doi: 10.1159/000329941
|
| 57 |
Jong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, Jae Berm Park, Joon Hyeok Lee, Sung Joo Kim, Seung Woon Paik, Cheol Keun Park, Byung Chul Yoo. Differences Between Hepatocellular Carcinoma and Hepatitis B Virus Infection in Patients With and Without Cirrhosis. Annals of Surgical Oncology 2014; 21(2): 458 doi: 10.1245/s10434-013-3302-1
|